Introduction
M etabolic investigations are essential in the de velopment of new drugs. Knowledge of biotransfor mation is required for a com parative evaluation of pharmacological and toxicological data. The im por tance of phase II m etabolites (e.g. glucuronic acid or sulphuric acid conjugates) is becoming increasingly recognized so that describing unconjugated m etabo lites or cleavage products alone is no longer suffi cient.
The investigation of m etabolite profiles, particu larly clean-up and purification for structural elucida tion of m etabolites is com plicated by several prob lems. The substances of interest are normally present in small quantities and low concentrations. Many en dogenous com pounds, several of which are present in large quantities, may interfere. The metabolites may be unstable. Their polarities cover a great range.
These problem s can largely be solved by using HPLC coupled with continuous radioactivity detec tion. The methodology has been known for more than ten years [1] [2] [3] [4] [5] [6] [7] [8] , however, the main advantage is not consistently made use of. Biological samples can be injected directly onto the H PLC column without prior clean-up due to the specificity of the detector [9] [10] [11] . To encourage other investigators to make use of the potential advantages of this methodology, we will discuss our experience in this report, part of which has already been published [3, 5, [12] [13] [14] [15] [16] .
First the general m ethodology will be presented, followed by the specific method used. Then several m etabolite patterns and m etabolite structures will be shown and the purification of metabolites for struc tural elucidation will be discussed.
Of course, this technique is not restricted to drug metabolism research in animals and man. In princi ple, it can be used for all biological systems in which tracer techniques are applied, e.g. biosynthesis studies [26] , microbiological transform ations in biotechnology, separation of labelled proteins [27] and nucleotides [28] . chrom atographic separation of these compounds. The reversed phase column combined with gradient elution is ideally suited for such separation problems. Selectivity can be increased by choosing m ultidimen sional conditions, e.g. separation with different pH. packing m aterial, eluant, tem perature. The specifici ty of the radioactivity detector makes it possible to inject biological fluids directly onto the column.
R adioactivity detection
Tritium and carbon-14 are the most commonly used radioactive isotopes in drug research. Radioac tivity detection of the column eluates can be made discontinuously or continuously in a flow-through cell. In our opinion, discontinuous detection is only suitable in cases where low concentrations of radioactivity are present with no possibility of enrich ment.
In continuous radioactivity detection, the meas urem ents in the hom ogenous phase are differen tiated from those in the heterogenous phase. In the hom ogenous phase, a scintillator solution is added to the column eluate, while during the m easurem ent in the heterogenous phase, the scintillator is present in the flow-through cell and is surrounded by the col umn eluate.
M easurem ent in hom ogenous phase
The m easurem ent in hom ogenous phase is impor tant mainly for the analysis of 3H -labelled sub stances. The lower detection limit is much better than with glass scintillators. With mixing ratios eluent: scintillator cocktail of 1:1 to 1:4, static count ing efficiencies of 20-50% are possible [8, 17] , A nother advantage is the avoidance of adsorption on the scintillator surface which is often seen by use of glass scintillators. Because of the short light ways in the cell, quenching is not as im portant as if m easured in scintillation vials, but may be significant with high eluate content [8, 18] ; com puter programs are avail able for quench correction.
An additional pulseless pum p for the scintillation cocktails is needed for m easurem ent in homogenous phase. In cases where the separated substances will be used for further investigations, e.g. structure elucidation, splitting techniques are indicated. In the case of very low radioactivity, a splitter controler can be used which can be driven by an internal standard or automatically to admit only radioactive fractions to the cell. The radioactive zones remain in the cell until the next radioactive peak is eluted. In this case, the counting time depends on the time between radioactive peaks. A nearly static m easurem ent is possible. Unmixable liquids can be inserted before and after a radioactive substance to avoid peak broadening, and the regions of interest can be stored in a large loop. W hen the chrom atogram is finished, the stored eluate is pum ped back through the detec tor and so the counting time can be regulated by the radioactivity in the eluate [20] ,
M easurement in heterogenous phase
For the flow-through cell, glass scintillators are normally used, (e.g. Cer-activated Lithium glass) or Yttrium silicate. Europium -activated CaF, scintil lators in plastic or organic substances such as anthra cene are of minor im portance. Using optimal crystal diam eter and cell dimensions, the static counting ef ficiency of glass scintillators and Y ttrium silicate range from 30-70% for l4C [18, 19, 21, 22] , and from 0.6-6% for tritium [8, 18, 22] .
The main advantage of glass scintillators is a po tential use of the eluate for further investigations. This is im portant for structure elucidation of sub stances from biological fluids e.g. urine, plasma, and bile as well as plant extracts. Due to low quench ing [21] , glass scintillators are well suited for quan titative determ inations.
Normally no m ajor adsorption problems occur with glass scintillators, but adsorption may be more frequent using Y ttrium silicate. Scintillators can be washed with alkaline detergents or acids. Sometimes adsorption can be avoided by silylation of the scintil lator surface.
The cell volumes normally used range from 25 to 500 |il for glass scintillators [18, 21] and from 100 to 2000 |il for the hom ogenous phase method [18] . These relatively large dead volumes, however, do not result in rem arkable peak broadening, if the peak volumes are larger than 1 ml.
Data collection and quantitative evaluation
Formerly the data from the radioactivity detector were collected by m ultichannel analyzer, but now microcomputers are used for this purpose. They have the advantage of being more flexible and user friend ly. The num ber of data points per time unit (e.g. the time resolution) depends on chrom atographic condi tions and storage space available. The chrom atogram can be observed "live" on a C R T and may be re corded simultaneously on a strip chart recorder. Sophisticated software enables various control func tions (e.g. controlling a fraction collector), quench correction, data storage on disc, data evaluation dur ing the run and reevaluation of stored data.
Data evaluation is done according to the user's requirem ents. For m etabolite profiles the user needs a report which lists the counts for individual peaks and the whole chromatogram as well as the back ground to calculate percentages of each peak on the total radioactivity. For com parative studies, chromatograms can be depicted in a 3-dimensional plot.
Simultaneously, the m icrocom puter can collect the data of a second radioactivity channel e.g. for d o u ble-labelled compounds as well as the data of UVand/or fluorescence detectors. cells, filled with cer-activated lithium glass (KochLight) or HS-scintillator (B erthold, W ildbad). For the measurements in the hom ogenous phase, scintil lation cocktail Rialuma (Baker) was used. For data evaluation multichannel analyzer BS 27 (BertholdSilena) with magnetic band station was used. The analog signals of the radioactivity and UV detectors and the gradient were registered on a 3-channel (Rikadenki) or 4-channel (Linseis) recorder. A ppli cation of the samples to the column was made using a loop injector (Rheodyn) with a 2 ml dosage loop.
The urine, bile, and plasma samples to be injected were adjusted to the required pH and filtered over a m em brane filter (Sartorius). For analytical runs the volumes were 1-5 ml; the radioactivity amounts in jected were 100,000 to 1 Mio dpm for urine and bile and 5,000-20,000 dpm for plasma. For preparative runs up to 11 urine was pum ped onto reversed phase-columns (16 mm i.d). 
Materials and M ethods

A nim al and human studies
Radioactivity dosage was 20 to 100 [iCi/kg in ani mals and 100 ^iCi per subject. All substances were administered orally in adequate dosages/specific ac tivities. U rine, bile, and plasma samples were deep frozen during or immediately after collection.
H P L C and radioactivity measurements
HPLC separations were carried out by means of a Varian 5000 using reversed phase columns (50 x 0.46 cm) packed with [x-Bondapak C-18, 10 urn (W aters) in our laboratory if not otherwise specified. A precolumn (4 x 0.46 cm) filled with the same material was installed for the protection of the separation column. For U V -detection an LC 55 photom eter (Perkin-Elm er) was used. Radioactivity was measured with radioactivity detector LB 5025 or LB 503 (Berthold, W ildbad), with 100 or 300 jj,l
Results and Discussion
The applicability of the system HPLC radioactivity detection in metabolite research is dem onstrated on the basis of drugs which were investigated in our laboratory.
M etabolite profiles in urine, bile, and plasm a [14C]Norfenefrine
The sympathomimetic norfenefrine is a strong hydrophylic substance and, like its m etabolites, im mediately eluated from the C-18 column, even in the presence of buffer solution. For this reason, analyses were conducted using tetrabutylam m onia ions as counter ions. The parent substance was still eluated early, but the metabolites could be separated with the aid of gradient elution (buffer vs acetonitrile).
The m etabolite profiles of norfenefrine in rats, dogs, cats, and man are given in Fig. 1 . The follow ing metabolic reactions were observed: glucuronic acid and sulphate conjugation of norfenefrine, as well as oxidative deamination in which 3-hydroxymandelic acid and 3-hydroxyphenylglycole were formed. The last two metabolites m entioned were also subject to conjugation reactions [12] .
Norfenefrine is a racem ate. The two enantiom eres of 3-hydroxymandelic acid formed in the organism could be separated on a reversed phase column using 
L-phenylalanine and cop p er sulphate solution as
eluents [23] , D ue to the strong polarity and relative instability of some of the substances described, a differentiated investigation of the metabolism using other methods was not possible. Fig. 1 shows the separation of the m etabolites in urine (A) and plasma (B). The profiles are qualita tively com parable. In plasma, the radioactivity con centrations are in the range of a few nCi/ml, so that analysis could only be m ade near the sensitivity limits of the radioactivity detector. In order to achieve maximum sensitivity, the flow was reduced to 0.2 ml x m in-1. The time duration of the radioactiv ity in the cell is thereby increased resulting in a better signal/noise ratio.
The human plasma sample (1.4 ml) contained 8.400 dpm. Due to the high load of the column with large amounts of plasma, the reproducibility of the [14C]Etozolin retention volumes was reduced. Therefore the The studigs Qn the metabolism of the diuretic metabolites were assigned to the pattern obtained in etozolin give an impressive example of the efficiency subsequent runs after addition of authentic unlabelancj pOWCr 0f the HPLC radioactivity detection led substances to the plasma. system The m etabolite profiles of urine and bile (Fig. 2) show seven com pounds, some of which were very unstable. Slight changes to alkaline or acidic pH caused artefact form ations due to ring opening of the thiazolidinone ring. In earlier studies several ar tefacts appeared during extraction, clean-up with A m berlite-X A D -2 chromatography and enzyme in cubations. Origination of metabolite profiles was only m ade possible when using the HPLC radioactiv ity detection system, since no clean-up was neces sary. Separation and enrichm ent was achieved under most careful conditions [5] .
Etozolin is a racem ate. Its main m etabolite (I), which is form ed by enzymatic cleavage of the ester bond, is esterified in the organism with ß -Dglucuronic acid to the diastereom eric glucuronic acid conjugates II and III. A lthough these m etabolites are highly unstable and racemize easily, it was possi ble to get a quantitative and qualitative description of their occurrences in urine using the HPLC radio activity detection system [5] ,
Thymoxamine is an a-blocking drug. The m etabo lite profiles in urine following oral administration of [14C]thymoxamine to rats, dogs, cats, and humans (Fig. 3) show large differences among the species [16] . The m etabolites which occurred were almost exclusively glucuronic and sulfuric acid conjugates. An interspecies comparison of the m etabolite pat terns using standard m ethods like enzyme incuba tion, extraction and thin-layer chrom atography would have been complicated for this substance, since the sulphate conjugates could not be cleaved with arylsulphatases of different sources (helix pom atia, Boehringer M annheim and limpets, Sig ma). On the other hand, it was relatively easy using the H PLC radioactivity detection m ethod, since the conjugates as such could be quantitatively deter mined in a single run.
Up to a few years ago, unchanged conjugates were rather disregarded in m etabolite studies, since they seem ed uninteresting from a pharmacological point of view. However, it has now been recognized that they can indeed show pharmacological activity. The sulphate conjugates (III) and (IV) are examples [24] , [?H]Naloxone Fig. 4 shows the m etabolite profiles of the opiate antagonist naloxone in urine and bile following oral adm inistration to rats, dogs, and humans. Biotrans form ation reactions are reduction of the carbonyl group, hydroxylation or splitting off the allyl group and conjugate form ation [13] .
All analyses shown were made in the homogenous phase, since the [3H ]concentration in humans was relatively low, concentration procedures were to be avoided and optimal comparability was to be at tained.
For the enrichm ent and purification of m etabolites to define structure, we made the radioactivity m eas urem ents in the heterogenous phase in order to avoid unnecessary loss of substance.
[3H ]Levobunolol Levobunolol is a potent non cardioselective ß-blocker. The m etabolite profiles in urine following oral adm inistration to mice, rats, dogs, and humans are given in Fig. 5 . The radioactivity was m easured in homogenous phase by means of the splitting techni que. There are great differences among species [14] , a fact which is relevant for the comparative interpre tation of pharmacological and toxicological data.
In previous investigations using TLC and hydroly sis of conjugates, quantitative data on metabolite composition could not be given and the main m etabolite III was not detected in man. However, m etabolite III has the same affinity to the ßr receptor as levobunolol and the dihydro m etabolite II [25] .
In our experim ents more than 95% of the urinary radioactivity could be described by identified metabolites.
Preparative work: Enrichm ent and purification o f m etabolites
Although MS-, IR-, or NM R-investigations can be done at the low |j,g-level, normally 50 to 300 jxg are required for structure elucidation. In most cases pre parative isolation of m etabolites is therefore re quired.
Principally the preparative isolation from urine can be done by columns which have the same quality and length as the analytical columns but their diam e ter has to be related to the urine volume and the am ount of substances. In some cases a concentration step may be advantageous prior to separation: urine is pum ped onto the RP-column and after washing with water the m etabolite mixture is eluted with a small volume of m ethanol. Ion exchange chrom ato graphy may be used for group separation to obtain groups of glucuronides, sulphates, unconjugates.
For purification of the separated metabolites sev eral different chrom atographic runs are necessary due to the m ultitude of endogenous compounds by varying stationary phase, eluent, pH , tem perature. Usually we needed about five purification steps. Simultaneous UV detection (one wave length or whole spectrum) is very useful to control success of purification. The last purification step includes the In principle, the technique described can of course separation from salts. A photo diode array detector be applied also for isolation of non-radioactive sub may give im portant inform ation on the structures. stances from biological material. In Fig. 6 the procedure for isolation and purifica tion of the levobunolol metabolites is shown in ex perimental detail as an example. Starting from 600 ml urine six metabolites (I, II, III, IX, X, XI) and the parent drug (LB) were isolated via five steps for subsequent structure identification by mass spec trometry. In the first step 10 jam filling material was used according to the needed high capacity. Separa tion from endogenous compounds was achieved in steps 2 to 5 using finer filling material, variation of step 1. pH and change of filling m aterial. Progress of purifi cation was controlled by simultaneous UV and fluorescence detection.
After structural elucidation an aliquot of the indi vidual metabolite should be used to determ ine reten-
